Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya.

Autor: Mutisya EM; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya. Emutisya@kaviuon.org., Muturi-Kioi V; IAVI, Nairobi, Kenya., Abaasa A; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda., Nyasani D; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Kabuti RW; SWOP-PHDA, University of Nairobi/University of Manitoba, Nairobi, Kenya., Lunani L; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Kotikot T; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Mundia M; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Mutua G; IAVI, Nairobi, Kenya., Ombati G; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Nduta H; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Price MA; IAVI, New York, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA., Kimani J; SWOP-PHDA, University of Nairobi/University of Manitoba, Nairobi, Kenya., Anzala AO; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya.; School of Medicine, College of Health Sciences, University of Nairobi, Nairobi, Kenya.

Publikováno v: BMC public health [BMC Public Health] 2022 Dec 20; Vol. 22 (1), pp. 2385. Date of Electronic Publication: 2022 Dec 20.

Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.

Autor: Nyasani DK; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Mutua GN; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Sajabi RM; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Ng'ang'a JW; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Gachie JN; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Maina AM; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Lusike LL; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya., Anzala AO; KAVI-Institute of Clinical Research, University of Nairobi, Nairobi, Kenya.; Department of Microbiology, School of Medicine, College of Health Sciences, University of Nairobi, Nairobi, Kenya., Price MA; International AIDS Vaccine Initiative, New York, United States of America.; Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California, United States of America., Manyonyi GO; Department of Microbiology, School of Medicine, College of Health Sciences, University of Nairobi, Nairobi, Kenya.

Publikováno v: PloS one [PLoS One] 2018 Nov 02; Vol. 13 (11), pp. e0206656. Date of Electronic Publication: 2018 Nov 02 (Print Publication: 2018).

Integrin α 4 β 7 expression on peripheral blood CD4 ⁺ T cells predicts HIV acquisition and disease progression outcomes.

Autor: Sivro A; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4013, South Africa.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada., Schuetz A; Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok 10400, Thailand.; U.S. Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute, Silver Spring, MD 20817, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817, USA., Sheward D; Division of Medical Virology and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service, Cape Town 7925, South Africa., Joag V; Department of Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada., Yegorov S; Department of Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada., Liebenberg LJ; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4013, South Africa., Yende-Zuma N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4013, South Africa., Stalker A; Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada., Mwatelah RS; Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada., Selhorst P; Division of Medical Virology and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service, Cape Town 7925, South Africa., Garrett N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4013, South Africa., Samsunder N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4013, South Africa., Balgobin A; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4013, South Africa., Nawaz F; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-9806, USA., Cicala C; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-9806, USA., Arthos J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-9806, USA., Fauci AS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-9806, USA., Anzala AO; Kenyan AIDS Vaccine Initiative, Nairobi 00202, Kenya.; Department of Medical Microbiology, University of Nairobi, Nairobi 00202, Kenya., Kimani J; Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada.; Department of Medical Microbiology, University of Nairobi, Nairobi 00202, Kenya., Bagaya BS; Uganda Virus Research Institute-International AIDS Vaccine Initiative HIV Vaccine Program, Plot 51-59, Nakiwogo Road, Entebbe, Uganda.; Department of Epidemiology and Biostatistics, Makerere University, P.O. Box 7062, Kampala, Uganda., Kiwanuka N; Uganda Virus Research Institute-International AIDS Vaccine Initiative HIV Vaccine Program, Plot 51-59, Nakiwogo Road, Entebbe, Uganda.; Department of Immunology and Molecular Biology, Makerere University, P.O. Box 7062, Kampala, Uganda., Williamson C; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4013, South Africa.; Division of Medical Virology and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service, Cape Town 7925, South Africa., Kaul R; Department of Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada.; University Health Network, Toronto, Ontario M5G IL7, Canada., Passmore JS; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4013, South Africa.; Division of Medical Virology and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town and National Health Laboratory Service, Cape Town 7925, South Africa.; National Health Laboratory Services, Cape Town 8005, South Africa., Phanuphak N; South East Asia Research Collaboration in HIV (SEARCH), The Thai Red Cross AIDS Research Centre, Bangkok 10330, Thailand., Ananworanich J; U.S. Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute, Silver Spring, MD 20817, USA.; South East Asia Research Collaboration in HIV (SEARCH), The Thai Red Cross AIDS Research Centre, Bangkok 10330, Thailand.; University of Amsterdam, 1000 GG Amsterdam, Netherlands., Ansari A; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA., Abdool Karim Q; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4013, South Africa.; Department of Epidemiology, Columbia University, New York, NY 10032, USA., Abdool Karim SS; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4013, South Africa.; Department of Epidemiology, Columbia University, New York, NY 10032, USA., McKinnon LR; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban 4013, South Africa.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada.; Department of Medical Microbiology, University of Nairobi, Nairobi 00202, Kenya.

Publikováno v: Science translational medicine [Sci Transl Med] 2018 Jan 24; Vol. 10 (425).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.